Varian Medical Systems ARIA Oncology Information System and Eclipse Treatment Planning Software Named 2015/2016 Category Leaders in the 2015/2016 Best in KLAS: Software and Services Report

On February 16, 2016 Varian Medical Systems (NYSE: VAR) reported its ARIA oncology information system and Eclipse treatment planning software have been named "2015/2016 Category Leader" in the "Best in KLAS: Software and Services Report" by KLAS, an independent research firm specializing in monitoring and reporting on the performance of healthcare vendors (Press release, InfiMed, FEB 16, 2016, View Source [SID:1234509075]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

In use in some 3,200 cancer treatment centers around the world, ARIA was named the "2015/2016 Category Leader" for Oncology software. ARIA is a comprehensive electronic medical record and image management system that aggregates patient data into an organized, oncology-specific medical chart with functional components for managing clinical, administrative and financial operations for medical, radiation and surgical oncology. The ARIA system provides a seamless flow of information for managing the patient’s entire journey—from diagnosis through follow-up.

ARIA users shared these comments posted on KLASresearch.com: a director stated, "ARIA is a great solution. It works well for both medical and radiation oncology." While a CIO shared these comments about the ARIA solution: "ARIA is tightly linked with the functionality of our linear accelerator, and that is incredible. That connection is what makes ARIA very valuable to our oncologists and radiologists. The linear accelerator is controlled through the software, so the charting and things we do with patients become almost invisible. All the documentation we have to do is automatically put in to the system. On the oncology side, all the formulas are streamlined. Doctors don’t have to look for a lot of things. There are a lot of customized fields doctors can set up."

For more information on ARIA, visit View Source

Named a "2015/2016 Category Leader" for Treatment Planning software for the third year in a row, the market and technology-leading Eclipse software is in use at some 3,400 cancer treatment centers around the world. The software creates an optimized radiotherapy treatment plan based on a physician’s dose instructions, and information about the size, shape and location of the tumor to be treated with radiation. The Eclipse software incorporates unique features such as RapidPlan knowledge-based planning, which makes it easier and faster to plan sophisticated cancer treatments like intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and RapidArc radiotherapy.

In comments posted on KLASresearch.com, a vice president who uses Eclipse said: "We really like Eclipse and feel it is the very best treatment planning software out there." A physicist using Eclipse stated: "We find it very easy to create good, efficient dose management using the system."

For more information on Eclipse, visit View Source

"These rankings acknowledge the hard work the Varian team has done. Working closely with oncology clinicians and administrators has allowed us to understand their needs, enhance the ARIA information system and Eclipse software, and provide the best-in-class tools for fighting cancer," said Kolleen Kennedy, president of Varian’s Oncology Systems business.

The 2015/2016 Best in KLAS report, published at the end of January, ranks healthcare vendors and their solutions by the professionals who use them—healthcare providers. For a full list of Best in KLAS winners, Global (Non-U.S.) Best in KLAS winners, and Category Leaders, visit View Source